WHCI
RMD icon

W.H. Cornerstone Investments’s ResMed RMD Stock Holding History

W.H. Cornerstone Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-812
Closed -$222K – 116
2025
Q3 		$222K Buy
812
+2
+0.2% +$546 0.14% 109
2025
Q2 		$209K Buy
+810
New +$193K 0.13% 109

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

W.H. Cornerstone Investments's RMD Position: Q4 2025 in Review

W.H. Cornerstone Investments sold out of ResMed (RMD) in Q4 2025, closing a stake of 812 shares — an estimated $222K sold.

W.H. Cornerstone Investments first reported a position in RMD in Q2 2025 and held it in 2 quarters. The position peaked at $222K in Q3 2025. 946 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • W.H. Cornerstone Investments reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • W.H. Cornerstone Investments sold 812 ResMed shares in Q4 2025, an estimated $222K.
  • W.H. Cornerstone Investments first reported a position in ResMed in Q2 2025 and held it in 2 quarters.
  • W.H. Cornerstone Investments's ResMed position peaked at $222K in Q3 2025.
  • 946 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on W.H. Cornerstone Investments's 13F filing for Q4 2025, filed 10 Feb 2026.